Guerbet S.A (GBT) | Stock Overview & Key Data
Guerbet S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €90.64 on March 27, 2017
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Guerbet S.A
GBT
|
127.29M Small-cap | -4.57% | -1.21% | 19.63% | -27.01% | -33.63% | -53.04% | -42.84% | -67.54% | -81.86% | -38.17% | -38.17% |
|
Eurobio Scientific
ALERS
|
229.56M Mid-cap | 1.34% | 1.34% | 0.89% | -6.39% | -6.00% | -12.55% | 52.53% | 19.00% | 178.75% | -5.51% | -5.51% |
|
Median Technologies
ALMDT
|
188.62M Mid-cap | -3.32% | 0.00% | 2.91% | 52.78% | 12.76% | 141.21% | -23.08% | -60.40% | -44.83% | -35.48% | -35.48% |
|
Affluent Medical
AFME
|
122.22M Small-cap | -4.82% | 9.09% | 26.32% | 134.97% | 88.76% | 146.48% | 171.32% | -55.97% | -55.97% | -55.97% | -55.97% |
|
Mauna Kea
ALMKT
|
37.44M Small-cap | 0.00% | -5.56% | -15.00% | 142.86% | 112.50% | 30.77% | -72.58% | -72.58% | -72.58% | -72.58% | -72.58% |
|
Diagnostic Medical
ALDMS
|
34.47M Small-cap | 6.56% | 0.00% | 2.36% | 4.84% | 1.56% | 3.23% | -10.49% | -15.23% | -28.89% | -39.91% | -39.91% |
Ownership & Short Interest
Calculate Your Guerbet S.A Investment Returns
Long-Term Investment Performance Analysis
Guerbet S.A stock price in Jul 2016 was €62.00, A €1,000.00 lump sum investment in Guerbet S.A made 9 years ago would be worth approximately €158.23 today, representing a negative return of -84.18%. This translates to an annualized return (CAGR) of -16.98%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is GBT's 52-week high and low?
- In the last 52 weeks, Guerbet S.A reached a high of €23.70 (on July 9, 2025) and a low of €8.01 (on March 17, 2026).
- What is the market cap and P/E ratio for GBT?
- Curious about Guerbet S.A's size and valuation? Its market capitalization stands at 127.29M. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.77, and the forward P/E (looking ahead) is 4.96.
- Does GBT pay dividends? If so, what's the yield?
- Yes, Guerbet S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.31%, and the company has paid an average of €0.62 per share annually over the past 3 years.
- Who are Guerbet S.A's main competitors or similar companies to consider before investing?
When looking at Guerbet S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurobio Scientific
ALERS229.56M Healthcare Medical Devices -12.55% 52.53% Median Technologies
ALMDT188.62M Healthcare Medical Devices 141.21% -23.08% Affluent Medical
AFME122.22M Healthcare Medical Devices 146.48% 171.32% Mauna Kea
ALMKT37.44M Healthcare Medical Devices 30.77% -72.58% Diagnostic Medical
ALDMS34.47M Healthcare Medical Devices 3.23% -10.49% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Guerbet S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Guerbet S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -34.58%, the Debt to Equity ratio from the most recent quarter is 169.65, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for GBT?
- Looking at Guerbet S.A's growth, its revenue over the trailing twelve months (TTM) was €799M. Compared to the same quarter last year (YoY), quarterly revenue grew by -5.20%, and quarterly earnings saw a YoY growth of N/A.
- How much of GBT stock is held by insiders and institutions?
- Wondering who owns Guerbet S.A stock? Company insiders (like executives and directors) hold about 63.21% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.33%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.